Updated Tesla Model 3 As ‘Go-To EV’ In New Review

Tesla Inc's (NASDAQ: TSLA) Model 3, dubbed the "Highland," has reportedly corrected many of the issues previously cited

Tesla Inc‘s (NASDAQ:TSLA) Model 3, dubbed the “Highland,” has reportedly corrected many of the issues previously cited with the original model, such as interior quality and ride comfort.

It also enhanced its visual appeal with design updates including slimmer headlights and a more refined front fascia.

Despite being introduced back in 2017 and rapidly rising to popularity by outselling other Tesla models combined, the Highland edition builds on its legacy with significant improvements.

The Model 3’s facelift not only makes it more aesthetically pleasing, but also improves its aerodynamics, which helps extend its driving range slightly. The interior is said to be more luxurious, with additions like Alcantara door cards and LED mood lighting.

These enhancements address previous criticisms of the car’s premium feel. Additionally, the vehicle now features a rear passenger screen and reconfigured storage solutions that add to its practicality and comfort.

Tesla has also adjusted the vehicle’s controls, removing traditional stalks and incorporating functions into a redesigned steering wheel, a change that has received mixed feedback from drivers. The suspension tweaks have made the ride smoother, though some may find it affects the car’s handling dynamics.

InsideEVs’ endorsement of the changes underscores the Model 3’s continuing appeal, even as it faces newer and competitively priced rivals globally.

Photo courtesy of Tesla

Total
0
Shares
Related Posts
Read More

Organic Growth And Innovation Drive YoY Increase In Cannabis Producer Organigram’s Q4 Revenue And Adjusted EBITDA

Canadian cannabis producer Organigram Holdings reported an 11% year-over-year increase in net revenue for the fourth quarter, reaching C$A161.6 million ($121 million). The company credited the growth to its focus on innovative products that meet consumer demand for convenience, such as pre-rolls and edibles. The increase in revenue contributed to a 71% rise in adjusted EBITDA to nearly CA$6m for the quarter, compared with the same period in 2022. Organigram's adjusted gross margin was CA$40.2m, up 20% on 2022. The company also reported a net loss of CA$248.6m, compared with CA$14.3m in 2022, due to impairments on property, plant and equipment, intangibles and goodwill. Organigram said it expects improved margins in future as efficiency gains from facility upgrades and expansion into higher-margin categories such as craft flower and vapes bear fruit.

OGI